Ishii, Masanobu
Kaikita, Koichi
Sato, Koji
Sueta, Daisuke
Fujisue, Koichiro
Arima, Yuichiro
Oimatsu, Yu
Mitsuse, Tatsuro
Onoue, Yoshiro
Araki, Satoshi
Yamamuro, Megumi
Nakamura, Taishi
Izumiya, Yasuhiro
Yamamoto, Eiichiro
Kojima, Sunao
Kim-Mitsuyama, Shokei
Ogawa, Hisao
Tsujita, Kenichi
Funding for this research was provided by:
Bayer Yakuhin
Shionogi
Sanofi K.K.
Otsuka Pharmaceutical
Boston Scientific Japan
Teijin Pharma
Kissei
Kyowa Hakko Kirin
MSD K.K.
Astellas Pharma
Novartis
Medtronic Japan
Takeda Pharmaceutical Company
Daiichi-Sankyo
Pfizer Japan
Dainippon Sumitomo Pharma
Chugai Pharmaceutical
Mitsubishi Tanabe Pharma Corporation
Boehringer Ingelheim Japan
Johnson and Johnson
Nihon Kohden America
Amgen
This article is maintained by: Elsevier
Article Title: Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction
Journal Title: JACC: Basic to Translational Science
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jacbts.2017.08.001
Content Type: article
Copyright: © 2017 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.